Leaky blood-brain barrier linked to Alzheimer's diseaseJune 01, 2016
Researchers using contrast-enhanced MRI have identified leakages in the blood-brain barrier (BBB) of people with early Alzheimer's disease (AD), according to a new study published online in the journal Radiology. The results suggest that increased BBB permeability may represent a key mechanism in the early stages of the disease.
The BBB, a collection of cells and subcellular structures in the cerebrovascular wall that separates the circulating blood from the brain, is essential to keep brain tissue in healthy condition. It regulates the delivery of important nutrients and blocks neurotoxins, while removing surplus substances from the brain.
For the study, researchers used contrast-enhanced MRI to compare 16 early AD patients with 17 healthy age-matched controls. They measured BBB leakage rates and generated a map called a histogram to help determine the amount of the leaking brain tissue.
The BBB leakage rate was significantly higher in AD patients compared with controls and the leakage was distributed throughout the cerebrum--the largest part of the brain. AD patients had a significantly higher percentage of leaking brain tissue in the gray matter, including the cortex, the brain's outer layer. The researchers also found that measurements derived from the histogram showed very subtle BBB impairment in the brain's white matter.
"Blood-brain barrier leakage means that the brain has lost its protective means, the stability of brain cells is disrupted and the environment in which nerve cells interact becomes ill-conditioned," said study author Walter H. Backes, Ph.D., from the Maastricht University Medical Center in Maastricht, the Netherlands. "These mechanisms could eventually lead to dysfunction in the brain."
Indeed, the researchers found a relationship between the extent of BBB impairment and decline in cognitive performance, suggesting that a compromised BBB is part of the early pathology of AD and might be part of a cascade of events eventually leading to cognitive decline and dementia.
The connection between BBB impairment and AD pathology was strengthened by the fact that the addition of diabetes and other non-cerebral vascular diseases to the analysis model did not change the results.
According to Dr. Backes, the key advantage of detecting BBB leakage with contrast MRI is that it can detect early microvascular changes in AD even in cases where no directly visible cerebrovascular abnormalities can be observed.
"For Alzheimer's research, this means that a novel tool has become available to study the contribution of blood-brain barrier impairment in the brain to disease onset and progression in early stages or pre-stages of dementia," he said.
"Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease." Collaborating with Dr. Backes were Harm J. van de Haar, M.Sc., Saartje Burgmans, Ph.D., Jacobus F. A. Jansen, Ph.D., Matthias J. P. van Osch, Ph.D., Mark A. van Buchem, M.D., Majon Muller, M.D., Paul A. M. Hofman, M.D., and Frans R. J. Verhey, M.D.
Radiology is edited by Herbert Y. Kressel, M.D., Harvard Medical School, Boston, Mass., and owned and published by the Radiological Society of North America, Inc.
RSNA is an association of more than 54,000 radiologists, radiation oncologists, medical physicists and related scientists promoting excellence in patient care and health care delivery through education, research and technologic innovation. The Society is based in Oak Brook, Ill. (RSNA.org)
For patient-friendly information on brain MRI, visit RadiologyInfo.org.
Radiological Society of North America
Related Blood-brain Barrier Current Events and Blood-brain Barrier News Articles
Using exercise to reduce glutamate build-up in the brain
In a new study published today in Applied Physiology, Nutrition, and Metabolism, scientists from the University of Guelph have found that exercise has the potential to decrease toxic build-up in the brain, reducing the severity of brain disorders such as Huntington's disease.
AACR: Results from clinical trial of personalized cellular therapy in brain tumors
Immune cells engineered to seek out and attack a type of deadly brain cancer known as glioblastoma (GBM) were found to have an acceptable safety profile and successfully migrate to and infiltrate tumors, researchers from Penn Medicine and Harvard University reported at the AACR Annual Meeting 2016 (Abstract LB-083).
New formulation of FDA-approved drug may help treat Niemann-Pick Type C disease
Niemann-Pick Type C (NPC) disease is a rare, fatal neurodegenerative disease for which there is currently no cure.
Antidepressant may improve cognitive symptoms in people with HIV
In a small, placebo-controlled clinical trial, Johns Hopkins physicians report that the antidepressant paroxetine modestly improves decision-making and reaction time, and suppresses inflammation in people with HIV-associated cognitive impairment.
Benefits of taking the natural pigment astaxanthin
A research group led by University of Tsukuba Professor Hideaki Soya and Professor Randeep Rakwal has investigated the effect on hippocampal function of the naturally derived pigment ASX, which is believed to have the most powerful antioxidant activity among carotenoids.
Antibody provide a more exact Alzheimer's diagnosis radioactive tracers
For the first time, researchers have succeeded in passing an antibody through the blood-brain barrier to act as a tracer for PET imaging of the brain.
Penn study: Visualizing a parasite crossing the blood brain barrier
An estimated 30 percent of the world's population is chronically infected with the parasite Toxoplasma gondii. Most people live with the infection without noticeable effect, but it can be life-threatening for people with suppressed immune systems, such as people on cancer therapies or who have HIV/AIDS.
New therapy halts progression of Lou Gehrig's disease in mice
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, for nearly two years in one type of mouse model used to study the disease - allowing the mice to approach their normal lifespan.
How recurrent strep A infections affect the brain
Researchers have discovered how immune cells triggered by recurrent Strep A infections enter the brain, causing inflammation that may lead to autoimmune neuropsychiatric disorders in children.
Gut bacteria make pomegranate metabolites that may protect against Alzheimer's disease
In a quest to stay healthy, many people are seeking natural ways to prevent neurodegenerative diseases.
More Blood-brain Barrier Current Events and Blood-brain Barrier News Articles